Buy
Strong Buy
Buy
Hold
Sell
Strong Sell
0
5
1
0
0
Icosavax, Inc.
Share · KR7002780005 · ICVX (XNAS)
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Icosavax, Inc.
Analyst Grade Summary
No Price
Share Float & Liquidity
Free Float 58,34 %
Shares Float 29,3 M
Shares Outstanding 50,23 M
Company Profile for Icosavax, Inc. Share
Icosavax, Inc., a biopharmaceutical company, develops vaccines against infectious diseases. The company, with the help of its virus-like particle (VLP) platform technology, focuses primarily on life-threatening respiratory diseases. Its products in pipeline include IVX-121, a vaccine candidate with RSV target and is under Phase 1/1b clinical trial; IVX-A12, a respiratory syncytial virus (RSV) monovalent antigen candidate with RSV/human metapneumovirus (hMPV) bivalent target indication; IVX-241, a vaccine candidate with hMPV target; and IVX-411, an original receptor binding domain (RBD) sequence antigen with SARS-CoV-2 target indication and is under Phase 1/2 clinical trial. The company was incorporated in 2017 and is headquartered in Seattle, Washington.
Company Data
Name Icosavax, Inc.
Company Icosavax, Inc.
Symbol ICVX
Website
https://icosavax.com
Primary Exchange 
NASDAQ
NASDAQ
ISIN KR7002780005
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Adam K. Simpson
Market Capitalization 769 Mio
Country United States of America
Currency USD
Employees 0,1 T
Address 1616 Eastlake Avenue East, 98102 Seattle
IPO Date 2021-07-29
Ticker Symbols
| Name | Symbol |
|---|---|
| NASDAQ | ICVX |
More Shares
Investors who hold Icosavax, Inc. also have the following shares in their portfolio:
